Results 31 to 40 of about 13,776 (222)
Comparison of Effects on Gene Expression Activity of Low-Molecular-Weight Lychee Fruit Polyphenol (Oligonol®), Adenosine, and Minoxidil in Human Dermal Papilla Cells [PDF]
Background: Oligonol® (OLG) is a functional food product and ingredient for cosmetics derived from a lychee fruit polyphenol. It has been reported to act on the skin as an anti-inflammatory and prevent UVB-induced skin damage.Aim: In this study, with the
Komatsu, K. (Ken-ichi) +6 more
core +3 more sources
Progressive renal disease: Role of race and antihypertensive medications [PDF]
Progressive renal disease: Role of race and antihypertensive medications. Hypertension is associated with an accelerated rate of decline in renal function in patients with chronic renal disease. To identify factors that might alter the rate of decline in
Peter C. Brazy +27 more
core +1 more source
Biology of human hair: Know your hair to control it [PDF]
Hair can be engineered at different levels—its structure and surface—through modification of its constituent molecules, in particular proteins, but also the hair follicle (HF) can be genetically altered, in particular with the advent of siRNA-based ...
A Dugour +173 more
core +1 more source
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar +4 more
doaj +1 more source
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram +2 more
doaj +1 more source
Drug-mediated shortening of action potentials in LQTS2 hiPSC-cardiomyocytes [PDF]
Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are now a well-established modality for modeling genetic disorders of the heart.
Denning, Chris +6 more
core +3 more sources
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FDA approved medical treatment for FPHL. However, the off-label botanically derived 5-alpha reductase inhibitors (5αRIs) are commonly used despite ...
Fairouz K Badran +2 more
doaj +1 more source
Cantú syndrome with coexisting familial pituitary adenoma [PDF]
Context: Pseudoacromegaly describes conditions with an acromegaly related physical appearance without abnormalities in the growth hormone (GH) axis. Acromegaloid facies, together with hypertrichosis, are typical manifestations of Cantú syndrome.
AD Irvine +23 more
core +2 more sources
Alopecia areata: a multifactorial autoimmune condition [PDF]
Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body. It can later progress to total loss of scalp hair (Alopecia totalis) and/
Butcher, John P. +3 more
core +1 more source
Pharmacological correction of retinal ischemia/reperfusion by minoxidil [PDF]
Introduction/Objective. The objective of this paper was to increase the effectiveness of pharmacological correction of retinal ischemia-reperfusion by using minoxidil. Methods. The research was carried out on 180 Wistar rats.
Peresypkina Anna A. +4 more
doaj +1 more source

